Concord Biotech has informed that in continuation of letter dated May 28, 2024 regarding Audio recording of the Audited (Standalone and Consolidated) Financial Results of the company for the Fourth Quarter and Year ended March 31, 2024, Earnings call for Investors and Analysts and pursuant to Regulation 30 (6) of the SEBI (Listing Obligations and Disclosure Requirements) 2015, the transcripts of the Earnings call for the said period enclosed and available on the website of the company at the following link. Also noted that this transcript and the audio recording of the call, both have been uploaded on website as follows: https://www.concordbiotech.com/investors
The above information is a part of company’s filings submitted to BSE.
